Life Technologies Launches EZQC™ Online, a Web-based Solution for Molecular Diagnostics Quality Control
New solution is an essential part of Life's strategy to ensure the quality of democratized molecular testing in the translational and clinical settings
CARLSBAD, Calif. – September 24, 2013 – Life Technologies Corporation announces the release of its EZQC™ Online, a web-based tool for quality control management in molecular diagnostic labs. EZQC™ Online contains three modules: a guidance tool for initial validation and verification of molecular tests; a tool to help labs meet CLIA standards for calibration verifications; and a tool for ongoing quality control monitoring that provides an opportunity for peer-to-peer comparisons.
EZQC™ Online streamlines validation of molecular assays and can collapse time of validation to as little as two days. The Validations/Verifications module includes a comprehensive database of guidelines and templates that can be utilized to quickly design validation protocols and analytical reports.
"Labs can sometimes spend up to two months researching guidelines and designing protocols before implementing a validation study for a new assay," said Linh Hoang, M.D., Ph.D., General Manager of AcroMetrix® quality control products at Life Technologies. "EZQCTM Online gathers extensive research into a searchable package that can accelerate this process, saving labs time and effort."
The tool's QC Monitoring module allows laboratories to monitor test performance on an ongoing basis, alerting personnel to data drift and to potential failures before they occur. In addition to tracking internal lab testing quality, the EZQC™ Online tool offers a unique feature through which labs can gauge the performance of their assays against other laboratories. The data are anonymized and levels of data sharing are set by each user to ensure confidentially of results.
"The networking feature provides a forum for labs to collaborate, sharing guidelines, experiences and any information they choose, which allows an opportunity for laboratory directors and technicians to learn from their peers and raise the overall standard of molecular testing," said Dr. Hoang.
The EZQC™ Online tool is an extension of the company's EZValidation™ Online Tool, which assists laboratories in verification and validation of molecular tests. EZValidation was selected by The Association of Public Health Laboratories (APHL) and made available to its member labs. APHL's members include state, territorial and local public health laboratories; state environmental testing laboratories; state agricultural and food safety laboratories; and individual scientists, public health officials and academicians.
About Life Technologies
Life Technologies Corporation is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Contact: